PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.87%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.68%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-2.71%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.45%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
25.02%
Dividend growth above 1.5x ADI's 0.81%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-7.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-9.93%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
66.42%
Similar 10Y revenue/share CAGR to ADI's 63.53%. Walter Schloss might see both firms benefiting from the same long-term demand.
96.86%
5Y revenue/share CAGR above 1.5x ADI's 34.54%. David Dodd would look for consistent product or market expansions fueling outperformance.
41.72%
3Y revenue/share CAGR above 1.5x ADI's 0.31%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
241.13%
10Y OCF/share CAGR above 1.5x ADI's 76.86%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
127.23%
Below 50% of ADI's 394.79%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
37.02%
3Y OCF/share CAGR 1.25-1.5x ADI's 26.04%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
401.02%
Net income/share CAGR above 1.5x ADI's 107.04% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
252.29%
5Y net income/share CAGR similar to ADI's 241.76%. Walter Schloss might see both on parallel mid-term trajectories.
93.61%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
91.65%
10Y equity/share CAGR at 50-75% of ADI's 131.34%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
10.40%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-4.05%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
361.20%
Dividend/share CAGR of 361.20% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
355.42%
Dividend/share CAGR of 355.42% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
294.10%
3Y dividend/share CAGR 1.25-1.5x ADI's 208.43%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
-13.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.21%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-7.70%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.50%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
-6.09%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.